指南与共识腹部技术与安全USMRCT

ACR适宜性标准® 慢性肝病

ACR Appropriateness Criteria® Chronic Liver Disease.
指南 / 共识 · J Am Coll Radiol · 2017-01-01

该指南由美国放射学会(ACR)制定,基于文献分析与RAND/UCLA适宜性方法及GRADE证据分级,评估慢性肝病影像检查的适宜性。指南指出超声诊断肝硬化不可靠且无法诊断早期可治疗肝纤维化,瞬时弹性成像、声辐射力脉冲超声弹性成像和MR弹性成像可评估肝纤维化;所有国际组织推荐超声筛查肝细胞癌,但超声在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者中识别肝细胞癌尤其受限,这些患者及肝移植等待名单患者可考虑用MRI或多期CT筛查肝细胞癌。

要点

  • 超声(灰阶和多普勒)诊断肝硬化不可靠,且无法诊断早期可治疗的肝纤维化。
  • 瞬时弹性成像、声辐射力脉冲超声弹性成像和MR弹性成像可评估肝纤维化。
  • 所有国际组织推荐超声筛查肝细胞癌,但超声在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者中识别肝细胞癌尤其受限。

核心结论

  • 超声诊断肝硬化不可靠且无法诊断早期可治疗的肝纤维化;瞬时弹性成像、声辐射力脉冲超声弹性成像和MR弹性成像可评估肝纤维化;所有国际组织推荐超声筛查肝细胞癌,但超声在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者中识别肝细胞癌尤其受限,这些患者及肝移植等待名单患者可考虑用MRI或多期CT筛查肝细胞癌;既往诊断并治疗过肝细胞癌的患者需持续监测复发。

研究设计与样本

  • 美国放射学会(ACR)适宜性标准,由多学科专家小组每年审查,基于同行评审期刊文献的广泛分析,采用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作适宜性进行评级;证据缺乏或不明确时可由专家意见补充。

诊断标准与关键数值

  • 超声(灰阶和多普勒)可诊断肝硬化,但利用形态学和超声特征诊断不可靠,且无法诊断早期可治疗的肝纤维化。
  • 瞬时弹性成像、声辐射力脉冲超声弹性成像和MR弹性成像可评估肝纤维化。
  • 所有国际组织推荐超声筛查肝细胞癌。
  • 超声在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者中识别肝细胞癌尤其受限,受限程度达到可考虑用MRI或多期CT筛查肝细胞癌。
  • 既往诊断并治疗过肝细胞癌的患者需持续监测复发。

临床应用与阅片要点

  • 所有国际组织推荐超声筛查肝细胞癌。
  • 在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者以及肝移植等待名单患者中,超声识别肝细胞癌尤其受限,可考虑用MRI或多期CT筛查肝细胞癌。
  • 既往诊断并治疗过肝细胞癌的患者需持续监测复发。
  • 超声(灰阶和多普勒)利用形态学和超声特征诊断肝硬化不可靠,且无法诊断早期可治疗的肝纤维化。
  • 瞬时弹性成像、声辐射力脉冲超声弹性成像和MR弹性成像可评估肝纤维化。

局限性

  • 超声(灰阶和多普勒)诊断肝硬化不可靠,且无法诊断早期可治疗的肝纤维化。
  • 超声在肥胖、非酒精性脂肪性肝病及结节性肝硬化患者中识别肝细胞癌尤其受限。
  • 证据缺乏或不明确时,专家意见可补充现有证据来推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Because liver fibrosis can be treated, it is important to diagnose liver fibrosis noninvasively and monitor response to treatment. Although ultrasound (grayscale and Doppler) can diagnose cirrhosis, it does so unreliably using morphologic and sonographic features and cannot diagnose the earlier, treatable stages of hepatic fibrosis. Transient elastography, ultrasound elastography with acoustic radiation force impulse, and MR elastography are modalities that can assess for hepatic fibrosis. Although all international organizations recommend ultrasound for screening for hepatocellular carcinoma, ultrasound is particularly limited for identifying hepatocellular carcinoma in patients with obesity, nonalcoholic fatty liver disease, and nodular cirrhotic livers. In these patient groups as well as patients who are on the liver transplant wait list, ultrasound is so limited that consideration can be made for screening for hepatocellular carcinoma with either MRI or multiphase CT. Additionally, patients who have been previously diagnosed with and treated for hepatocellular carcinoma require continued surveillance for recurrent hepatocellular carcinoma. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Horowitz JM, Kamel IR, Arif-Tiwari H, et al. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol. 2017. PMID: 29101980. doi:10.1016/j.jacr.2017.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。